Infant RSV immunoprophylaxis changes nasal epithelial DNA methylation at six years of age
Cheng‐Jian Xu, Nienke M. Scheltema, Cancan Qi, Rolf Vedder, Laura B. C. Klein, Elisabeth E. Nibbelke, Cornelis Korstiaan van der Ent, Louis Bont, Gerard H. Koppelman
This study shows that infant RSV immunoprophylaxis with palivizumab alters nasal epithelial DNA methylation at age 6, affecting antiviral defense pathways but not asthma.
Pediatric Pulmonology · Sep 2, 2021Peer-reviewedGenetic & Genomic Medicine